SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 228.66 |
| Enterprise Value ($M) | 132.83 |
| Book Value ($M) | 175.63 |
| Book Value / Share | 2.13 |
| Price / Book | 1.30 |
| NCAV ($M) | 119.21 |
| NCAV / Share | 1.44 |
| Price / NCAV | 1.92 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.98 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.75 |
| Current Ratio | 3.75 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 271.14 |
| Assets | 327.57 |
| Liabilities | 151.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.09 | 0.00 | |
| 13G/A | State Street Corp | 3.00 | -46.37 | |
| 13G/A | Deep Track Capital, LP | 6.70 | 21.80 | |
| 13G/A | BlackRock, Inc. | 9.60 | 6.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 681,293 | 2,350,430 | 28.99 | |
| 460,992 | 1,567,183 | 29.42 | |
| 309,314 | 1,124,104 | 27.52 | |
| 501,923 | 1,366,227 | 36.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DNLI – Denali Therapeutics Inc. | DSGN – Design Therapeutics, Inc. |
| DVAX – Dynavax Technologies Corporation | ELEV – Elevation Oncology, Inc. |
| ELVN – Enliven Therapeutics, Inc. |